The Business Advisory Board is composed of leaders in the life-sciences and finance world with experience in the pharmaceutical, biotechnology, medical device, investment banking, venture capital and financial management industries. The BAB members assess grant and investment opportunities and provide advice and direction to support the commercialization of new therapies. The BAB members also work with the SAB and the Board in setting strategic direction to guide the organization and our programs.

  • Stephen D. Collins, M.D., Ph.D.:  Co-Chair, Business Advisory Board
    President & CEO, NeuroTherapeutics Pharma, Inc.
  • Garry E. Menzel, Ph.D.: Co-Chair, Business Advisory Board
    Executive Vice President Corporate Development and Finance, Regulus Therapeutics
  • Karen L. Bergman
    Founder and Principal, BCC Partners
  • Thomas A. Bologna
    President & Chief Executive Officer, Orchid Cellmark, Inc.
  • Frank Fischer
    President & CEO, NeuroPace, Inc.
  • Jeffrey D. Glidden
    Executive Vice President & Chief Financial Officer, Parametric Technology Corporation
  • Nina Graves, PharmD.
    Retired (Former) Epilepsy Program Director, Medtronic Inc.
  • Warren Lammert
    Founder, Managing Partner Granite Point Capital
  • Lisa Lindahl
    Chief Executive Instigator at EZL Enterprises and Co-Founder and Partner at Bellisse
  • Heath Lukatch, Ph.D.
    Partner, Novo Ventures
  • Daniel J. O'Connell
    Director, NeuroVentures Capital LLC
  • Sherrie Perkins
    Senior Director New Business Development, Cyberonics, Inc.
  • David A. Sadock
    President & CEO, Ethos Health Communications
  • Aaron Sandoski
    Managing Director, Norwich Ventures
  • Nancy Santilli, B.S.N., M.S.N.
    VP Commercial Strategy and Portfolio Planning, Endo Pharmaceuticals, Inc.
  • Ned Scheetz
    Managing Director, Aphelion Capital, LLC
  • Randy Siegel
    President, Local Digital Strategy, Advance Publications, Inc.
  • Lauren Silverman, Ph.D. 
    Managing Director, Novartis Option Fund
  • Matthew Simonian
    Senior Director, Epilepsy Marketing, Cyberonics, Inc.
  • Reese S. Terry, Jr.
    Founder, Cyberonics, Inc.
  • Elizabeth S. Weiswasser
    Litigation Partner, Weil, Gotshal & Manges LLP
  • Gregory T. Went, Ph.D.
    Chief Executive Officer and Chairman, Adamas Pharmaceuticals, Inc.
ADVERTISEMENT
ADVERTISEMENT